NCT03120117

Brief Summary

This is a prospective study to assess the feasibility and success of performing an intra-operative standing cough test and the correlation with the long term success of the sling surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
87

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

April 14, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 19, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

April 19, 2017

Status Verified

April 1, 2017

Enrollment Period

4.3 years

First QC Date

April 14, 2017

Last Update Submit

April 18, 2017

Conditions

Keywords

Midurethral Slings

Outcome Measures

Primary Outcomes (2)

  • Number of patients who present with recurrence of stress incontinence following sling surgery as assessed by post-operative cough test.

    Success criteria will be defined through the examination of patient's post-operative visits regarding cough stress tests in supine, sitting and standing positions where the bladder is at 10% of urodynamic fullness. Failure to meet this criteria will be considered recurrence of stress incontinence.

    Within first two years following sling procedure

  • Number of patients who present with recurrence of stress incontinence following sling surgery as assessed by post-operative MESA questionnaire.

    Success criteria is also defined through the examination of patient's response to Medical Epidemiologic and Social Aspects of Aging 12 (MESA) to determine recurrence of stress incontinence. Failure to meet this criteria will be considered recurrence of stress incontinence.

    Within first two years following sling procedure

Study Arms (1)

Cough Test following Sling Surgery

EXPERIMENTAL

All subjects enrolled will undergo sling surgery for treatment of stress urinary incontinence and subsequently asked to do a standing cough test.

Procedure: Cough Test following Sling Surgery

Interventions

Enrolled subjects will undergo sling surgery who present with stress-dominated urinary incontinence. While in the operating room, the subject will be asked to stand and cough to determine if there is still leakage once the sling has been placed.

Also known as: DISST Procedure
Cough Test following Sling Surgery

Eligibility Criteria

Age21 Years - 89 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who present with stress-dominant urinary incontinence
  • Patients who have undergone a stress test documentation both in the supine and standing/sitting position.
  • Patients who have completed child bearing.
  • Patients between 21 and 89 years of age.

You may not qualify if:

  • Patients who do not agree to participate and do not sign the informed consent.
  • Patients undergoing concomitant surgery
  • Patients undergoing surgery under anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Advanced Urogynecology of Michigan, P.C.

Dearborn, Michigan, 48124, United States

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Salil Khandwala, MD

    Michigan Institute of Women's Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

April 14, 2017

First Posted

April 19, 2017

Study Start

August 1, 2013

Primary Completion

December 1, 2017

Study Completion

January 1, 2018

Last Updated

April 19, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations